Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.06 -0.01 (-0.72%)
As of: Oct 21, 2026 · 11:16 AM EDT

Black Diamond Therapeutics (BDTX) Other financing activities (2019)

Updated

Black Diamond Therapeutics' Other financing activities came in at $1.34 million for Q4 2019, up 295.0% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Other financing activities (2019) Analysis & Trends

For FY2019, Black Diamond Therapeutics' Other financing activities was $1.74 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn
10 Black Diamond Therapeutics 117.89 Mn -375.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -1.34 Mn
Sep 30, 2019 -338,000.00
API Access

Black Diamond Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=BDTX&period=max&api_key=YOUR_API_KEY